Author/Authors :
Mehrabani Natanzi، Mahboobeh نويسنده Dietary Supplements and Probiotic Research Center, Alborz University of Medical Sciences, Karaj, IR Iran Mehrabani Natanzi, Mahboobeh , Ghaderian ، Sayyed Mohammad Hossein نويسنده Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences & Health Services,Tehran, Iran Ghaderian , Sayyed Mohammad Hossein , Khodaii، Zohreh نويسنده Department of Biochemistry, Nutrition, Medical Genetics, Faculty of Medicine, Alborz University of Medical Sciences & Health Services, Karaj, Iran ,
Abstract :
Probiotic products are matrices for delivery of beneficial live bacteria to the host. The viable bacteria are being incorporated into dairy products as well as supplements. The aim of the present study was evaluation and validation of probiotic contents in commercial products to select the optimum matrix for protection of viability and functionality of probiotic bacteria. A total of forty six lactic acid bacteria were isolated from ten pharmaceutical and ten dairy products. Their probiotic properties such as acid, salt and bile tolerance, antibiotic susceptibility tests, adherence to cell line, stability under refrigeration conditions and antagonistic activity against nine bacterial strains were assayed. Results showed that the viable bacterial count of solid products were lower than stated number on their package. No difference was noticed between strains isolated from dairy and non-dairy products regarding antibiotic susceptibility and adherence properties. Pharmaceutical isolates were more potent against pathogens than dairy isolates. In conclusion, dairy products are better matrices for delivering bifidobacteria than non-dairy products. But, probiotic isolates from non-dairy products, showed better properties such as pathogen exclusion than dairy isolates.
